CA2455805C - Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques - Google Patents
Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques Download PDFInfo
- Publication number
- CA2455805C CA2455805C CA2455805A CA2455805A CA2455805C CA 2455805 C CA2455805 C CA 2455805C CA 2455805 A CA2455805 A CA 2455805A CA 2455805 A CA2455805 A CA 2455805A CA 2455805 C CA2455805 C CA 2455805C
- Authority
- CA
- Canada
- Prior art keywords
- lysine
- protein
- glycated
- diabetic
- fructose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/794,433 US6004958A (en) | 1997-02-05 | 1997-02-05 | Compounds and methods for therapeutic intervention in preventing diabetic complications and procedures for assessing a diabetic's risk of developing complications and determining the efficacy of therapeutic intervention |
US08/794,433 | 1997-02-05 | ||
CA002279428A CA2279428C (fr) | 1997-02-05 | 1998-02-05 | Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002279428A Division CA2279428C (fr) | 1997-02-05 | 1998-02-05 | Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2455805A1 CA2455805A1 (fr) | 1998-08-06 |
CA2455805C true CA2455805C (fr) | 2011-05-10 |
Family
ID=32094412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2455805A Expired - Fee Related CA2455805C (fr) | 1997-02-05 | 1998-02-05 | Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2455805C (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2664606B1 (fr) * | 2012-04-25 | 2016-09-14 | Ueno Fine Chemicals Industry, Ltd. | Inhibiteur de la production de produits terminaux de glycation avancée |
-
1998
- 1998-02-05 CA CA2455805A patent/CA2455805C/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2455805A1 (fr) | 1998-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2279428C (fr) | Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques | |
US8431527B2 (en) | Methods for alleviating deleterious effects of 3-deoxyglucosone | |
EP1115389A1 (fr) | Fructosamine-oxydase: antagonistes et inhibiteurs | |
AU773401B2 (en) | Compounds and their therapeutic use with diabetic complications | |
EP1085885B1 (fr) | Procede permettant d'evaluer le risque du diabetique connaissant un etat pathologique associe aux diabetes | |
CA2455805C (fr) | Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques | |
US8138227B2 (en) | Method for inhibiting or reversing non-enzymatic glycation | |
Krooth et al. | Effect of 6-azauracil, and of certain structurally similar compounds, on three pyridoxal-phosphate requiring enzymes involved in neurotransmitter metabolism | |
WILSON et al. | Investigation of the 5-hydroxylation of thiabendazole in rat liver microsomal preparations | |
CA2344690C (fr) | Fructosamine-oxydase: antagonistes et inhibiteurs | |
Nyström | On endothelial function in type 2 diabetic patients with coronary artery disease | |
Pirola | Structure and Mechanism of Action of 5-aminolevulinate Synthase | |
NZ539272A (en) | Using an antagonist or an inhibitor of Fructosamine oxidase to reduce minimising the effects of macrovascular and microvascular damage in a diabetic patient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20130205 |